Guardant Health’s precision oncology tests - Guardant Reveal
TM
, Guardant360® CDx, and Guardant360 TissueNext
TM
are now available from Codex Genetics.
Bioinformatics
Products & Services
Hereditary Cancer Test
Neurodegenerative Disease Test
Drug Response Test
Congenital Cardiovascular Disease
Guardant Health Pan-Cancer Test
Guardant Shield™
Retinitis Pigmentosa
Professionals
About Us
Codex Cares
News and Events Hub
Blog
Careers
中文
eShop
Bioinformatics
Products & Services
Products & Services
Hereditary Cancer Test
Neurodegenerative Disease Test
Drug Response Test
Congenital Cardiovascular Disease
Guardant Health Pan-Cancer Test
Guardant Shield™
Retinitis Pigmentosa
Professionals
About Us
About Us
Codex Cares
News and Events Hub
Blog
Careers
中文
eShop
Cancer Therapy
Somatic Mutation and Germline Mutation in Cancer
Date：2022-03-02
Why should breast cancer patients confirm PIK3CA mutation?
Date：2021-12-14
Companion Diagnostics: integration of Diagnostic Testing into Treatment Pathway
Date：2021-12-13
Early Detection of BRCA Gene Mutations and Tackle the Refractory Triple-Negative Breast Cancer
Date：2020-10-07
RNA-based NGS – the best way to identify NTRK gene fusion
Date：2020-09-02
NTRK Gene Fusion: A Burgeoning Marker for Pan-Cancer Targeted Therapy
Date：2020-09-02
We use cookies to ensure that you have the best experience on our website. If you continue to use this site we assume that you accept this.
OK
